Published in PLoS One on December 20, 2012
Potential cardiovascular risk protection of bilirubin in end-stage renal disease patients under hemodialysis. Biomed Res Int (2014) 0.82
Serum calcium and incident diabetes: an observational study and meta-analysis. Osteoporos Int (2015) 0.77
Association of Adiponectin with High-Sensitivity C-Reactive Protein and Clinical Outcomes in Peritoneal Dialysis Patients: A 3.5-Year Follow-Up Study. PLoS One (2015) 0.75
Adiponectin and adiponectin receptors. Endocr Rev (2005) 8.46
Plasma adiponectin levels and risk of myocardial infarction in men. JAMA (2004) 7.46
Predictors and consequences of altered mineral metabolism: the Dialysis Outcomes and Practice Patterns Study. Kidney Int (2005) 3.56
Adiponectin acts in the brain to decrease body weight. Nat Med (2004) 3.47
Adiponectin: more than just another fat cell hormone? Diabetes Care (2003) 3.30
Adiponectin and coronary heart disease: a prospective study and meta-analysis. Circulation (2006) 2.89
Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure. Circulation (2005) 2.81
Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. J Clin Endocrinol Metab (2001) 2.73
Adiponectin is an independent predictor of all-cause mortality, cardiac mortality, and myocardial infarction in patients presenting with chest pain. Eur Heart J (2006) 2.47
Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease. J Am Soc Nephrol (2002) 2.46
Magnesium. An update on physiological, clinical and analytical aspects. Clin Chim Acta (2000) 2.45
Hypomagnesemia in patients with type 2 diabetes. Clin J Am Soc Nephrol (2007) 1.90
Association of adiponectin with coronary heart disease and mortality: the Rancho Bernardo study. Am J Epidemiol (2006) 1.85
Gender-specific association of adiponectin as a predictor of progression of chronic kidney disease: the Mild to Moderate Kidney Disease Study. Kidney Int (2007) 1.83
Renal insulin resistance syndrome, adiponectin and cardiovascular events in patients with kidney disease: the mild and moderate kidney disease study. J Am Soc Nephrol (2005) 1.74
Adiponectin: stability in plasma over 36 hours and within-person variation over 1 year. Clin Chem (2003) 1.70
Adiponectin and mortality in patients with chronic kidney disease. J Am Soc Nephrol (2006) 1.70
Circulating adiponectin levels are associated with better glycemic control, more favorable lipid profile, and reduced inflammation in women with type 2 diabetes. J Clin Endocrinol Metab (2005) 1.62
Circulating adiponectin levels and mortality in elderly men with and without cardiovascular disease and heart failure. Arch Intern Med (2007) 1.57
Dietary glycemic index, glycemic load, cereal fiber, and plasma adiponectin concentration in diabetic men. Diabetes Care (2005) 1.57
Adiponectin isoforms in elderly patients with or without coronary artery disease. J Am Geriatr Soc (2010) 1.52
Prognostic value of adiponectin for cardiovascular disease and mortality. J Clin Endocrinol Metab (2008) 1.37
Adiponectin and renal function, and implication as a risk of cardiovascular disease. Am J Cardiol (2006) 1.30
Relationship between magnesium and clinical biomarkers on inhibition of vascular calcification. Am J Nephrol (2011) 1.17
Altered calcium homeostasis is correlated with abnormalities of fasting serum glucose, insulin resistance, and beta-cell function in the Newfoundland population. Diabetes (2005) 1.16
Serum magnesium concentration is a significant predictor of mortality in maintenance hemodialysis patients. Magnes Res (2007) 1.14
Adiponectin and mortality in patients undergoing coronary angiography. J Clin Endocrinol Metab (2006) 1.11
Adiponectin in renal disease: relationship to phenotype and genetic variation in the gene encoding adiponectin. Kidney Int (2004) 1.07
Plasma adiponectin concentration before and after successful kidney transplantation. Transplant Proc (2003) 1.07
Adiponectin in essential hypertension. J Nephrol (2002) 1.03
Up-regulation of adiponectin, its isoforms and receptors in end-stage kidney disease. Nephrol Dial Transplant (2006) 1.01
Intra- and extracellular magnesium levels and atheromatosis in haemodialysis patients. Magnes Res (2004) 1.00
Magnesium and outcomes in patients with chronic kidney disease: focus on vascular calcification, atherosclerosis and survival. Clin Kidney J (2012) 1.00
Adiponectin: linking the metabolic syndrome to its cardiovascular consequences. Expert Rev Cardiovasc Ther (2005) 0.98
Magnesium in chronic kidney disease Stages 3 and 4 and in dialysis patients. Clin Kidney J (2012) 0.98
Dialysate calcium profiling during hemodialysis: use and clinical implications. Kidney Int (2002) 0.96
Association of serum adiponectin levels with all-cause mortality in hemodialysis patients. Intern Med (2008) 0.95
Adiponectin in chronic kidney disease has an opposite impact on protein-energy wasting and cardiovascular risk: two sides of the same coin. Clin Nephrol (2009) 0.93
Effect of surgery on cardiovascular risk factors in mild primary hyperparathyroidism. J Clin Endocrinol Metab (2009) 0.92
Mineral metabolism and mortality in patients with chronic kidney disease. Adv Chronic Kidney Dis (2007) 0.91
Primary hyperparathyroidism, insulin resistance, and cardiovascular disease: a review. Nurs Clin North Am (2007) 0.90
Waist circumference modifies the relationship between the adipose tissue cytokines leptin and adiponectin and all-cause and cardiovascular mortality in haemodialysis patients. J Intern Med (2010) 0.88
Serum adiponectin complexes and cardiovascular risk in children with chronic kidney disease. Pediatr Nephrol (2011) 0.87
High stable serum adiponectin levels are associated with a better outcome in prevalent dialysis patients. Am J Nephrol (2009) 0.87
Dialysate magnesium level and blood pressure. Kidney Int (2004) 0.85
Optimizing the dialysate calcium concentration in bicarbonate haemodialysis. Nephrol Dial Transplant (2012) 0.85
Plasma adiponectin concentrations are associated with body composition and plant-based dietary factors in female twins. J Nutr (2008) 0.85
Intracellular magnesium and adipokines in umbilical cord plasma and infant birth size. Pediatr Res (2007) 0.85
Calcium is involved in formation of high molecular weight adiponectin. Metab Syndr Relat Disord (2008) 0.84
Serum adiponectin multimer complexes and liver cancer risk in a large cohort study in Japan. Asian Pac J Cancer Prev (2009) 0.83
Reciprocal association of plasma adiponectin and serum C-reactive protein concentration in haemodialysis patients with end-stage kidney disease--a follow-up study. Nephron Clin Pract (2005) 0.82
Serum calcium levels are associated with novel cardiometabolic risk factors in the population-based CoLaus study. PLoS One (2011) 0.82
High-calcium dialysate: a factor associated with inflammation, malnutrition and mortality in non-diabetic maintenance haemodialysis patients. Nephrology (Carlton) (2010) 0.82
Association of the circulating adiponectin concentration with coronary in-stent restenosis in haemodialysis patients. Nephrol Dial Transplant (2006) 0.80
Hypertension and abnormal glucose homeostasis. Possible role of divalent ion metabolism. Am J Med (1989) 0.79
Circulating leptin and adiponectin levels in patients with primary hyperparathyroidism. Metabolism (2007) 0.78
Vascular calcifications as a footprint of increased calcium load and chronic inflammation in uremic patients: a need for a neutral calcium balance during hemodialysis? Int J Artif Organs (2002) 0.76
The kinase Akt1 controls macrophage response to lipopolysaccharide by regulating microRNAs. Immunity (2009) 3.58
Signalling networks regulating cyclooxygenase-2. Int J Biochem Cell Biol (2006) 2.66
Akt1 and Akt2 protein kinases differentially contribute to macrophage polarization. Proc Natl Acad Sci U S A (2012) 1.97
Relation of proximal aorta stiffness to left ventricular diastolic function in patients with end-stage renal disease. J Am Soc Echocardiogr (2007) 1.95
Systemic levels of interleukin-6 and matrix metalloproteinase-9 in patients with multiple myeloma may be useful as prognostic indexes of bone disease. Clin Chem Lab Med (2005) 1.93
The 'self-plagiarism' oxymoron: can one steal from oneself? Eur J Clin Invest (2012) 1.49
Adiponectin induces TNF-alpha and IL-6 in macrophages and promotes tolerance to itself and other pro-inflammatory stimuli. Biochem Biophys Res Commun (2005) 1.26
Neurosteroids as modulators of neurogenesis and neuronal survival. Trends Endocrinol Metab (2008) 1.25
Effect of statin treatment on renal function and serum uric acid levels and their relation to vascular events in patients with coronary heart disease and metabolic syndrome: a subgroup analysis of the GREek Atorvastatin and Coronary heart disease Evaluation (GREACE) Study. Nephrol Dial Transplant (2006) 1.24
The prevalence of the metabolic syndrome using the National Cholesterol Educational Program and International Diabetes Federation definitions. Curr Med Res Opin (2005) 1.22
Corticotropin-releasing hormone augments proinflammatory cytokine production from macrophages in vitro and in lipopolysaccharide-induced endotoxin shock in mice. Infect Immun (2002) 1.22
Peritoneal dialysis-associated peritonitis: clinical features and predictors of outcome. Int J Infect Dis (2009) 1.20
Corticotropin-releasing factor and the urocortins induce the expression of TLR4 in macrophages via activation of the transcription factors PU.1 and AP-1. J Immunol (2006) 1.12
Prevalence of vascular disease in metabolic syndrome using three proposed definitions. Int J Cardiol (2006) 1.12
Effects of 12 months treatment with L-selenomethionine on serum anti-TPO Levels in Patients with Hashimoto's thyroiditis. Thyroid (2007) 1.12
Adiponectin promotes endotoxin tolerance in macrophages by inducing IRAK-M expression. J Immunol (2009) 1.12
Awareness, treatment and control of the metabolic syndrome and its components: a multicentre Greek study. Hellenic J Cardiol (2006) 1.02
Relationship between serum levels of vascular endothelial growth factor, hepatocyte growth factor and matrix metalloproteinase-9 with biochemical markers of bone disease in multiple myeloma. Clin Chim Acta (2006) 1.02
Urocortin 1 and Urocortin 2 induce macrophage apoptosis via CRFR2. FEBS Lett (2005) 1.02
Comparison of four definitions of the metabolic syndrome in a Greek (Mediterranean) population. Curr Med Res Opin (2010) 1.01
Akt2 deficiency protects from acute lung injury via alternative macrophage activation and miR-146a induction in mice. J Immunol (2013) 1.01
Dehydroepiandrosterone and allopregnanolone protect sympathoadrenal medulla cells against apoptosis via antiapoptotic Bcl-2 proteins. Proc Natl Acad Sci U S A (2004) 1.01
Liver enzymes: potential cardiovascular risk markers? Curr Pharm Des (2011) 1.01
Vasoactive intestinal peptide suppresses toll-like receptor 4 expression in macrophages via Akt1 reducing their responsiveness to lipopolysaccharide. Mol Immunol (2008) 0.99
Tpl2 and ERK transduce antiproliferative T cell receptor signals and inhibit transformation of chronically stimulated T cells. Proc Natl Acad Sci U S A (2008) 0.99
Arterial stiffness alterations during hemodialysis: the role of dialysate calcium. Nephron Clin Pract (2007) 0.98
Acute renal failure, translocational hyponatremia and hyperkalemia following intravenous immunoglobulin therapy. Nephron Clin Pract (2007) 0.98
Neurosteroids as endogenous inhibitors of neuronal cell apoptosis in aging. Ann N Y Acad Sci (2006) 0.97
Prevalence of atherosclerotic vascular disease among subjects with the metabolic syndrome with or without diabetes mellitus: the METS-GREECE Multicentre Study. Curr Med Res Opin (2004) 0.97
A feasibility study for the provision of electronic healthcare tools and services in areas of Greece, Cyprus and Italy. Biomed Eng Online (2011) 0.97
The PI3K/Akt/mTOR pathway is activated in murine lupus nephritis and downregulated by rapamycin. Nephrol Dial Transplant (2010) 0.96
Corticotropin-releasing hormone induces Fas ligand production and apoptosis in PC12 cells via activation of p38 mitogen-activated protein kinase. J Biol Chem (2002) 0.95
Corticotropin releasing factor receptor 1 (CRF1) and CRF2 agonists exert an anti-inflammatory effect during the early phase of inflammation suppressing LPS-induced TNF-alpha release from macrophages via induction of COX-2 and PGE2. J Cell Physiol (2007) 0.94
The corticotropin-releasing factor (CRF) family of neuropeptides in inflammation: potential therapeutic applications. Curr Med Chem (2005) 0.93
The effect of apolipoprotein E polymorphism on the response to lipid-lowering treatment with atorvastatin or fenofibrate. J Cardiovasc Pharmacol Ther (2006) 0.91
Incidence, clinical, microbiological features and outcome of bloodstream infections in patients undergoing hemodialysis. Int J Med Sci (2013) 0.91
Low serum testosterone, arterial stiffness and mortality in male haemodialysis patients. Nephrol Dial Transplant (2011) 0.90
Prolactin levels, endothelial dysfunction, and the risk of cardiovascular events and mortality in patients with CKD. Clin J Am Soc Nephrol (2011) 0.90
Treating to target patients with primary hyperlipidaemia: comparison of the effects of ATOrvastatin and ROSuvastatin (the ATOROS study). Curr Med Res Opin (2006) 0.89
Parathyromatosis and the challenge of treatment. Am J Kidney Dis (2006) 0.89
Corticotropin Releasing Factor promotes breast cancer cell motility and invasiveness. Mol Cancer (2009) 0.88
Expression of the Tpl2/Cot oncogene in human T-cell neoplasias. Mol Cancer (2004) 0.88
Clinicopathologic predictors of death and ESRD in patients with pauci-immune necrotizing glomerulonephritis. Am J Kidney Dis (2003) 0.87
Androgen deficiency and endothelial dysfunction in men with end-stage kidney disease receiving maintenance hemodialysis. Am J Nephrol (2006) 0.87
Evidence for activation of the unfolded protein response in collagen IV nephropathies. J Am Soc Nephrol (2013) 0.87
Dehydroepiandrosterone: an ancestral ligand of neurotrophin receptors. Endocrinology (2015) 0.86
G protein-associated, specific membrane binding sites mediate the neuroprotective effect of dehydroepiandrosterone. FASEB J (2006) 0.86
Early effects of simvastatin versus atorvastatin on oxidative stress and proinflammatory cytokines in hyperlipidemic subjects. Angiology (2006) 0.85
Prevalence of metabolic syndrome according to different definitions in a hypertensive population. Angiology (2011) 0.85
The hypolipidaemic effects of Spirulina (Arthrospira platensis) supplementation in a Cretan population: a prospective study. J Sci Food Agric (2013) 0.85
Atorvastatin for diabetic macular edema in patients with diabetes mellitus and elevated serum cholesterol. Ophthalmic Surg Lasers Imaging (2010) 0.84
The actin cytoskeleton in rapid steroid hormone actions. Cytoskeleton (Hoboken) (2014) 0.84
Alendronate reduces serum TNFalpha and IL-1beta, increases neutrophil counts, and improves bone mineral density and bone metabolism indices in patients with chronic idiopathic neutropenia (CIN)-associated osteopenia/osteoporosis. J Bone Miner Metab (2004) 0.84
Can a left internal jugular catheter be used in the hemodialysis of a patient with persistent left superior vena cava? Hemodial Int (2007) 0.84
Total and corrected antioxidant capacity in hemodialyzed patients. BMC Nephrol (2003) 0.83
Atrial fibrillation, inflammation and statins. Hellenic J Cardiol (2006) 0.83
Identifying and attaining LDL-C goals: mission accomplished? Next target: new therapeutic options to raise HDL-C levels. Curr Drug Targets (2007) 0.82
Peripheral factors in the metabolic syndrome: the pivotal role of adiponectin. Ann N Y Acad Sci (2006) 0.82
Acute rhabdomyolysis caused by Spirulina (Arthrospira platensis). Phytomedicine (2008) 0.82
Biopsy-proven resolution of renal light-chain deposition disease after autologous stem cell transplantation. Nephrol Dial Transplant (2010) 0.82
Elderly patients with trochanteric hip fracture have lower serum Vitamin D levels compared to patients with cervical hip fracture. Arch Gerontol Geriatr (2010) 0.81
Adiponectin and cardiovascular remodeling in end-stage renal disease and co-morbid diabetes mellitus. Am J Nephrol (2006) 0.81
The calcineurin-nuclear factor of activated T cells signaling pathway mediates the effect of corticotropin releasing factor and urocortins on catecholamine synthesis. J Cell Physiol (2012) 0.81
Effect of antihypertensive treatment on plasma fibrinogen and serum HDL levels in patients with essential hypertension. Clin Appl Thromb Hemost (2005) 0.80
Evaluation of bone disease in multiple myeloma: a correlation between biochemical markers of bone metabolism and other clinical parameters in untreated multiple myeloma patients. Clin Chim Acta (2002) 0.80
The metastatic potential of human pancreatic cell lines in the liver of nude mice correlates well with cathepsin B activity. Int J Gastrointest Cancer (2003) 0.80
The estrogenic burden on vascular risk in male-to-female transsexuals. Curr Pharm Des (2010) 0.79
Baseline plasma levels of interleukin-8 in stage IV non-small-cell lung cancer patients: relationship with nutritional status and prognosis. Nutr Cancer (2011) 0.79
Delays incurred during acute myocardial infarction: a comparative study of rural and urban populations in Greece. Rural Remote Health (2010) 0.79
Losartan affects glomerular AKT and mTOR phosphorylation in an experimental model of type 1 diabetic nephropathy. J Histochem Cytochem (2013) 0.79
The impact of stress on tumor growth: peripheral CRF mediates tumor-promoting effects of stress. Mol Cancer (2010) 0.79
Lipid lowering drugs and gallstones: a therapeutic option? Curr Pharm Des (2011) 0.79
Kidney function and estimated vascular risk in patients with primary dyslipidemia. Open Cardiovasc Med J (2009) 0.79
Stress neuropeptides in the human endometrium: paracrine effects on cell differentiation and apoptosis. Hormones (Athens) (2006) 0.79
Neuropeptide urocortin and its receptors are expressed in rat Kupffer cells. Neuroendocrinology (2006) 0.79
Intravenous administration of vitamin B12 in the treatment of hyperhomocysteinemia associated with end-stage renal disease. J Nephrol (2003) 0.79
Roles of protein kinase A (PKA) and PKC on corticotropin-releasing hormone (CRH)-induced elevation of cytosolic calcium from extra-and intra-cellular sources. Hormones (Athens) (2006) 0.79
Percutaneous ethanol injection therapy: a surgery-sparing treatment for primary hyperparathyroidism. Clin Endocrinol (Oxf) (2008) 0.78
Rapamycin induced ultrastructural and molecular alterations in glomerular podocytes in healthy mice. Nephrol Dial Transplant (2012) 0.78
A novel role of peripheral corticotropin-releasing hormone (CRH) on dermal fibroblasts. PLoS One (2011) 0.78
Neurosteroid dehydroepiandrosterone exerts anti-apoptotic effects by membrane-mediated, integrated genomic and non-genomic pro-survival signaling pathways. J Neurochem (2008) 0.78